1. In Vivo Blood Kinetics and Transcript Integrity of Three mRNA-Lipid Nanoparticle Vaccines in Humans
Kent Sj, Li S, Amarasena Th, Reynaldi A, Leeming Mg, Juno Ja, Et Al.
mRNA-lipid nanoparticle (LNP) vaccines are detectable in human blood after vaccination, but platform-specific differences in systemic persistence and transcript integrity remain poorly defined. We analyzed serial blood samples from 73 participants receiving Moderna mRNA-1273 (three formulations), Pfizer/BioNTech…
- PEG immunogenicity
- PEGylated lipid nanoparticle
- SARS-CoV-2
- bio−nano interactions
- mRNA degradation
- nanoparticle clearance and biodistribution
- vaccine pharmacokinetics
